What It Is
Epithalon (also spelled Epitalon or Epithalone) is a synthetic tetrapeptide with the sequence alanine-glutamic acid-aspartic acid-glycine, abbreviated Ala-Glu-Asp-Gly or AEDG.[1] It grew out of research on Epithalamin, a bovine pineal-gland extract, largely through the work of Russian researcher Vladimir Khavinson and colleagues on what they termed "peptide bioregulators" -- a research framework, not a recognized pharmaceutical drug class.[2]
Epithalon is a research compound, not a consumer therapeutic. "Epitalon" is the spelling used by PubChem and most PubMed-indexed literature; both names refer to the same molecule.
How It Works
The central hypothesis behind Epithalon is that it can influence telomerase, the enzyme complex that adds repetitive DNA sequences to chromosome ends (telomeres) and helps preserve chromosomal stability during cell division.[3] A widely cited 2003 study reported that Epithalon induced telomerase activity and telomere elongation in human somatic cells.[4]
Separately, related research reported changes in nighttime melatonin rhythm in elderly people and aged monkeys, which is why Epithalon comes up in pineal-signaling and circadian-rhythm discussions.[7] These are proposed mechanisms from laboratory and animal findings, not confirmed human pathways, and telomerase biology is complicated by the fact that the same enzyme is active in many cancers.
What the Research Shows
The strongest evidence for Epithalon is preclinical. Beyond the 2003 telomerase findings, a 2025 study reported telomere-length changes in several human cell lines after Epitalon exposure.[5] Animal studies examining aging biomarkers, lifespan, and tumor incidence in mice found no change in food intake, body weight, or average lifespan, though some aging biomarkers and later-life survival measures were affected.[10]
Human evidence is limited and dated: a small 2002 report described a positive effect in most treated cases of a degenerative retinal condition, and separate studies described melatonin-rhythm changes in elderly subjects and aged monkeys.[9] These studies are small, old, and unreplicated in large modern trials, so they should be read as preliminary leads, not proof that Epithalon treats disease, reverses aging, or extends human lifespan.
Safety & Side Effects
Modern, large-scale human safety data for Epithalon do not exist. Older pineal-peptide reports describe general tolerability, but nothing resembling the adverse-event reporting expected of an approved drug.
- FDA has stated it has not identified safety information about Epitalon's proposed routes of administration sufficient to know whether it would cause harm in humans[14]
- Potential immunogenicity from aggregation or peptide-related impurities in compounded product[14]
- Unknown effects of repeated exposure on telomerase-related cancer risk
- No defined safety profile for pregnancy, breastfeeding, or use alongside other medications
These gaps mean the absence of reported harm should be read as an absence of scrutiny, not a safety guarantee.
Regulatory Status
Epithalon is not FDA-approved for any general, longevity, or sleep-related use in the United States. Epitalon did receive an FDA orphan-drug designation record dated September 2, 2010 for retinitis pigmentosa, but that same record lists the approval status as "Not FDA Approved for Orphan Indication" -- the designation reflects a development-incentive application, not marketing approval.[13]
FDA has separately flagged potential safety concerns for compounded Epitalon, and as of mid-2026 had scheduled a Pharmacy Compounding Advisory Committee meeting to discuss Epitalon-related bulk substances, with insomnia listed as the use under evaluation.[15] A scheduled discussion is not an approval, and no compounded or over-the-counter Epithalon product carries FDA-reviewed labeling.
Related Names and Compounds
Epithalon's naming is easy to conflate with related terms. Epithalamin is the original crude pineal-gland extract; Epithalon (or Epitalon) is the defined synthetic tetrapeptide studied out of that research line; and Vilon is a separate, related bioregulator peptide from the same research group.[2] Human mortality and longevity claims tied to Epithalamin extract should not be assumed to transfer to synthetic Epithalon unless a study specifically tested it.[19]
Melatonin, the well-characterized pineal hormone, is sometimes mentioned alongside Epithalon since both appear in circadian-rhythm research, but they are distinct molecules with different evidence bases and are not interchangeable.